A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to evaluate the safety and therapeutic equivalence of generic
ingenol mebutate gel, 0.05% to Picato gel, 0.05% and to establish the superiority of the
efficacy of these two products over the vehicle gel in the treatment of Actinic Keratosis
(AK) on the trunk or extremities.